Cardiovascular Systems (CSII) Tops Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil, producer inflation weaken
- Oil falls more than 3% on weaker global demand outlook and US crude buildup
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Cardiovascular Systems, Inc. Reports Fiscal 2020 Fourth-Quarter Financial Results
August 4, 2020 4:05 PM EDTConference Call Scheduled for Today, August 4, 2020, at 3:30 PM CT (4:30 PM ET)
Revenues of $42.5 million decreased 37.6% from fourth quarter last year Net loss was $15.2 million, or $0.43 per basic and diluted share Fiscal year 2020 revenues declined 4.6% to $236.5 million Equity issuance raised $135.0 million in net proceeds Management provides fiscal 2021 first quarter revenue guidance of $55 million to $58 millionST. PAUL, Minn.--(BUSINESS WIRE)-- Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative... More
